Specifically, while findings suggest that the CCL25/CCR9 axis is a key element in the immunosuppressive microenvironment of PCa and likely regulated by NAT10, additional molecular evidence is necessary to definitively confirm whether NAT10 influences CCL25 and CCR9 expression through the ac4C acetylation pathway. The gene discussed is CCR9; the disease is posterior cortical atrophy.